Business Description
cbdMD Inc
NAICS : 325412
SIC : 2834
ISIN : US12482W4087
Total Employee Number:
42Description
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.96 | |||||
Equity-to-Asset | 0.63 | |||||
Debt-to-Equity | 0.27 | |||||
Debt-to-EBITDA | -1.86 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -17.4 | |||||
Beneish M-Score | -2.08 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -71.8 | |||||
3-Year EBITDA Growth Rate | 89.8 | |||||
3-Year EPS without NRI Growth Rate | 79.5 | |||||
3-Year FCF Growth Rate | 83.7 | |||||
3-Year Book Growth Rate | -83.7 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 54.43 | |||||
9-Day RSI | 47.72 | |||||
14-Day RSI | 44.8 | |||||
3-1 Month Momentum % | -21.53 | |||||
6-1 Month Momentum % | -27.58 | |||||
12-1 Month Momentum % | -20.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.5 | |||||
Quick Ratio | 1.43 | |||||
Cash Ratio | 0.69 | |||||
Days Inventory | 124.51 | |||||
Days Sales Outstanding | 22.5 | |||||
Days Payable | 50.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -275.1 | |||||
Shareholder Yield % | 4.49 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 57.68 | |||||
Operating Margin % | -13.87 | |||||
Net Margin % | -13.8 | |||||
EBITDA Margin % | -5.69 | |||||
FCF Margin % | -11.51 | |||||
OCF Margin % | -10.6 | |||||
ROE % | -36.24 | |||||
ROA % | -25.11 | |||||
ROIC % | -40.47 | |||||
3-Year ROIIC % | -66.66 | |||||
ROC (Joel Greenblatt) % | -76.76 | |||||
ROCE % | -34.65 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.22 | |||||
PB Ratio | 0.67 | |||||
Price-to-Tangible-Book | 0.92 | |||||
EV-to-EBIT | -1.95 | |||||
EV-to-EBITDA | -4.77 | |||||
EV-to-Revenue | 0.27 | |||||
EV-to-Forward-Revenue | 0.98 | |||||
EV-to-FCF | -2.35 | |||||
Price-to-GF-Value | 3.11 | |||||
| Price-to-Net-Current-Asset-Value | 1.99 | |||||
Earnings Yield (Greenblatt) % | -51.28 | |||||
FCF Yield % | -43.2 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:YCBD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
cbdMD Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 20.932 | ||
| EPS (TTM) ($) | -0.306 | ||
| Beta | 1.8955 | ||
| 3-Year Sharpe Ratio | -0.38 | ||
| 3-Year Sortino Ratio | -0.63 | ||
| Volatility % | 154.42 | ||
| 14-Day RSI | 44.8 | ||
| 14-Day ATR ($) | 0.037521 | ||
| 20-Day SMA ($) | 0.508093 | ||
| 12-1 Month Momentum % | -20.2 | ||
| 52-Week Range ($) | 0.4521 - 2.56 | ||
| Shares Outstanding (Mil) | 11.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
cbdMD Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
cbdMD Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| First quarter earnings conference call for 2027 | 2027-02-17 16:20 | In 162 days | ||
| First quarter earnings results for 2027 | 2027-02-17 | In 161 days | ||
| Annual report for 2026 | 2026-12-18 | In 100 days | ||
| Third quarter earnings conference call for 2026 | 2026-08-13 16:20 | 0.60 (+2.31%) | ||
| Third quarter earnings results for 2026 | 2026-08-13 | 0.60 (+2.31%) | ||
| Second quarter earnings conference call for 2026 | 2026-05-14 16:20 | 0.80 (+3.57%) | ||
| Second quarter earnings results for 2026 | 2026-05-14 | 0.80 (+3.57%) | ||
| General meeting for 2026 | 2026-03-30 11:00 | 0.72 (-1.65%) | ||
| First quarter earnings conference call for 2026 | 2026-02-17 16:20 | 0.70 (+2.36%) | ||
| First quarter earnings results for 2026 | 2026-02-17 | 0.70 (+2.36%) |
Show
Entries
cbdMD Inc Frequently Asked Questions
What is cbdMD Inc(YCBD)'s stock price today?
The current price of YCBD is $0.50. The 52 week high of YCBD is $2.56 and 52 week low is $0.45.
When is next earnings date of cbdMD Inc(YCBD)?
The next earnings date of cbdMD Inc(YCBD) is 2026-12-19 Est..
Does cbdMD Inc(YCBD) pay dividends? If so, how much?
cbdMD Inc(YCBD) does not pay dividend.
Press Release
Articles on cbdMD Inc
cbdMD Inc (YCBD) (Q3 2026) Earnings Call Highlights: Strategic Pivot and Cost Cuts Aim to Offset Regulatory Headwinds
Aug 14, 2026
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers